Bristol picks ZS to handle commercial analytics in vendor consolidation move

Bristol-Myers Squibb ($BMY) has selected ZS to support its commercial analytics. The deal makes ZS Bristol's primary vendor in the sector, allowing the Big Pharma to trim the list of vendors with which it works to analyze commercial data. ZS won the contract on the strength of its 20-year working relationship with Bristol and capabilities of its Analytics Process Optimization tool. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.